2019 BioHealth Capital Region Forum

Top 3 by 2023

Miss the 2019 BioHealth Capital Region Forum?

 

20% of the top influencers worldwide in vaccine development

 

World-class tech + big data + biotech + White House Precision Medicine Initiative = new frontiers in patient-centered medicine

1
1

MD | DC | VA

Our Goal: To become a Top 3 BioHealth Hub by 2023.

We are the research engine for the nation and the world. A lifeblood of support for taking new medicines to market. A place where health policymakers and patient advocates seek a better way forward. A home to the established and the startup, pioneering big ideas for human health and hope.

Driving Innovation and Entrepreneurship

  • World–renowned research institutions and universities
  • Influential policymakers and advocacy groups pioneering new health strategies
  • World–leading infectious disease research and vaccine development
  • Fastest growing region for healthcare companies in the U.S.
  • Rated #1 in the nation for science and engineering talent
  • Mission control for the National Cancer Moonshot Initiative

Founding Partners

The Catalyst: Creating Innovation in Health Care – United Therapeutics’ Martine Rothblatt at Healthy Returns

May 23, 2019

There are few, if any, more innovative, more daring, and more iconic health care executives. We’ll hear about the process that drives groundbreaking invention, and her dream of permanently alleviating…

Regenxbio building Maryland AAV plant to support gene therapies

May 22, 2019

Regenxbio will construct a GMP facility in Maryland to produce adeno-associated viral vectors for its gene therapy programs using its NAV technology-based platform. The good manufacturing practice (GMP) plant will…

QIAGEN’s QuantiFERON®-TB Access development program gains recognition from United Nations initiative for health innovation

May 21, 2019

HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)–May 21, 2019– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QuantiFERON ® -TB Access, a new solution under development for diagnosis…

Navitas Life Sciences Announces Acquisition of KAI Research, US-based Full-service Contract Research Organisation (CRO)

May 21, 2019

PRINCETON, N.J., May 21, 2019 /PRNewswire/ — Navitas Life Sciences, a TAKE Solutions Enterprise today announced the acquisition of US based niche full service CRO and health research company, KAI Research Inc. KAI Research…

Montgomery County Economic Development Corporation (MCEDC) Launches New Bio Lab Pilot

May 14, 2019

ROCKVILLE, Md.–(BUSINESS WIRE)– Helps Fund Wet Lab Space for Small Biotech Companies The Montgomery County Economic Development Corporation (MCEDC) launches a year-long pilot program designed to help small biotech companies…

Beltsville biopharm closes IPO, grosses nearly $90M

May 14, 2019

The net proceeds from the IPO, along with NextCure’s cash on hand, will largely be used to drive its lead product, NC318, through clinical trials and testing. Read more via…